AJDIN KOBIC: Open Payments
NPI 1104321587 · BOLIVAR, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$809 in 28 payments from 12 companies in 2025. Trend: 2023 $125 · 2024 $665 · 2025 $809
Food & beverage: $709Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $206 |
| LEO Pharma Inc. | 4 | $122 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $120 |
| UCB, Inc. | 3 | $102 |
| Novartis Pharmaceuticals Corporation | 3 | $85 |
| ABBVIE INC. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Genentech USA, Inc. | 1 | $18 |
| Incyte Corporation | 1 | $16 |
Products named: TREMFYA, Bimzelx, ANZUPGO, SKYRIZI, COSENTYX, ADBRY, Sotyktu, Rhapsido.
Industry payments across MO — which companies pay providers there.
